Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Antinuclear Antibodies Detected by Automated Immunofluorescence

By LabMedica International staff writers
Posted on 13 May 2013
Antinuclear and anticytoplasmic antibodies are important diagnostic markers for systemic rheumatic diseases and autoimmune hepatitis. More...


The diagnostic performance of automated systems for image acquisition and interpretation of indirect immunofluorescence-based tests for antinuclear antibodies are increasingly being used.

Scientists at the Catholic University Leuven (Leuven, Belgium) measured by automated indirect immunofluorescence 268 consecutive samples submitted to the laboratory for antinuclear antibody testing. Included in the study were in 231 patients with a systemic rheumatic disease at the time of diagnosis, 143 blood donors, 134 patients with chronic fatigue syndrome, and 133 diseases controls whose diagnosis of systemic rheumatic disease was excluded.

Antinuclear antibodies were detected by Zenit G-Sight (A. Menarini Diagnostics, Florence, Italy), an automated system for image acquisition and interpretation of indirect immunofluorescence-based tests. The automated fluorescence microscope uses a light-emitting diode (LED) light source with a 450–490 nm bandwidth and is equipped with a motorized precision stage for up to five slides and a Charged Coupled Device (CCD) color camera.

Image acquisition by G-Sight was of high quality and the accuracy of pattern assignment was limited. There was a significant correlation between automated estimation of fluorescence intensity, known as the probability index of positivity and end-point titer. Probability index interval specific likelihood ratios for systemic rheumatic disease increased with increasing level of positivity probability. Probability indexes were higher with the transfected mitotic human epithelioid (Hep-2000) cell substrate (Immunoconcepts; Sacramento, CA, USA) than with the human epithelial cell (Hep-2) substrate. The probability indexes reached a plateau at titer 160 with the Hep-2000 substrate.

The authors concluded that G-Sight offers high quality image acquisition. The accuracy of pattern assignment is limited and needs to be further developed. There was a significant correlation between probability indexes, a measure of fluorescence intensity and antibody titer, and the probability indexes provided by G-Sight, which afforded clinically useful information. Test result specific likelihood ratios help with the interpretation of data generated by automated immunofluorescence analysis of antinuclear antibodies. The study was published on the January 16, 2013, in the journal Clinica Chimica Acta.

Related Links:
Catholic University Leuven
A. Menarini Diagnostic
Immunoconcepts



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.